Literature DB >> 16859834

Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme.

F E Studer1, D E Fedele, A Marowsky, C Schwerdel, K Wernli, K Vogt, J M Fritschy, D Boison.   

Abstract

Adenosine is a potent modulator of excitatory neurotransmission, especially in seizure-prone regions such as the hippocampal formation. In adult brain ambient levels of adenosine are controlled by adenosine kinase (ADK), the major adenosine-metabolizing enzyme, expressed most strongly in astrocytes. Since ontogeny of the adenosine system is largely unknown, we investigated ADK expression and cellular localization during postnatal development of the mouse brain, using immunofluorescence staining with cell-type specific markers. At early postnatal stages ADK immunoreactivity was prominent in neurons, notably in cerebral cortex and hippocampus. Thereafter, as seen best in hippocampus, ADK gradually disappeared from neurons and appeared in newly developed nestin- and glial fibrillary acidic protein (GFAP)-positive astrocytes. Furthermore, the region-specific downregulation of neuronal ADK coincided with the onset of myelination, as visualized by myelin basic protein staining. After postnatal day 14 (P14), the transition from neuronal to astrocytic ADK expression was complete, except in a subset of neurons that retained ADK until adulthood in specific regions, such as striatum. Moreover, neuronal progenitors in the adult dentate gyrus lacked ADK. Finally, recordings of excitatory field potentials in acute slice preparations revealed a reduced adenosinergic inhibition in P14 hippocampus compared with adult. These findings suggest distinct roles for adenosine in the developing and adult brain. First, ADK expression in young neurons may provide a salvage pathway to utilize adenosine in nucleic acid synthesis, thus supporting differentiation and plasticity and influencing myelination; and second, adult ADK expression in astrocytes may offer a mechanism to regulate adenosine levels as a function of metabolic needs and synaptic activity, thus contributing to the differential resistance of young and adult animals to seizures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859834     DOI: 10.1016/j.neuroscience.2006.06.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  80 in total

1.  Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.

Authors:  Eleonora Aronica; Emanuele Zurolo; Anand Iyer; Marjolein de Groot; Jasper Anink; Caterina Carbonell; Erwin A van Vliet; Johannes C Baayen; Detlev Boison; Jan A Gorter
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

2.  Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Authors:  Panos Theofilas; Sukhmani Brar; Kerry-Ann Stewart; Hai-Ying Shen; Ursula S Sandau; David Poulsen; Detlev Boison
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

3.  Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?

Authors:  Tianfu Li; Nikki Lytle; Jing-Quan Lan; Ursula S Sandau; Detlev Boison
Journal:  Glia       Date:  2011-09-30       Impact factor: 7.452

4.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

5.  Expression of nucleoside transporter in freshly isolated neurons and astrocytes from mouse brain.

Authors:  B Li; L Gu; L Hertz; L Peng
Journal:  Neurochem Res       Date:  2013-09-12       Impact factor: 3.996

Review 6.  The adenosine-mediated, neuronal-glial, homeostatic sleep response.

Authors:  Robert W Greene; Theresa E Bjorness; Ayako Suzuki
Journal:  Curr Opin Neurobiol       Date:  2017-06-19       Impact factor: 6.627

Review 7.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

Review 8.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

9.  Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Authors:  M Wu; P Sahbaie; M Zheng; R Lobato; D Boison; J D Clark; G Peltz
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

10.  Developmental role of adenosine kinase for the expression of sex-dependent neuropsychiatric behavior.

Authors:  D M Osborne; U S Sandau; A T Jones; J W Vander Velden; A M Weingarten; N Etesami; Y Huo; H Y Shen; D Boison
Journal:  Neuropharmacology       Date:  2018-08-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.